| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6168487 | Urology | 2011 | 6 Pages |
Abstract
During the 4-year study, dutasteride was associated with a decreased risk of BPH progression in men with mild-to-moderate symptoms and normal or enlarged prostates.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Claus G. Roehrborn, J. Curtis Nickel, Gerald L. Andriole, R. Paul Gagnier, Libby Black, Timothy H. Wilson, Roger S. Rittmaster,